Bright Peak Therapeutics

Bright Peak Therapeutics is a biotechnology company. Bright Peak is developing next-generation engineered cytokines for immuno-oncology indications, with a platform capable of chemically synthesizing and optimizing natural proteins. Bright Peak Therapeutics is committed to improving the efficacy of proteins as drugs and addressing various challenges, including extending the half-life of cytokines, fusing them with antibodies, and devising masking strategies to enable cytokines to function under specific conditions.